ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine Serous Carcinoma

Authors: Joyce F. Liu, Nicoletta Colombo, Amit M. Oza, Jean-Sebastien Frenel, Bradley R. Corr, Maria M. Rubinstein, Nicole S. Nevadunsky, Stephanie Lheureux, Lydia Gaba, Lucía González Cortijo, Vanda Salutari, Benoit You, Sarah Chiang, Mark J. O'Connor, Lenka Oplustil O'Connor, Didier Meulendijks, Mahmuda Khatun, Dana Ghiorghiu, Ana Oaknin

Published: 2025-04-22

DOI: 10.1200/jco-24-01606

Source: Full article

---

Abstract

PURPOSE